Matt Devalaraja

1.1k total citations · 1 hit paper
8 papers, 541 citations indexed

About

Matt Devalaraja is a scholar working on Molecular Biology, Nephrology and Hematology. According to data from OpenAlex, Matt Devalaraja has authored 8 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Nephrology and 2 papers in Hematology. Recurrent topics in Matt Devalaraja's work include Erythropoietin and Anemia Treatment (2 papers), Iron Metabolism and Disorders (2 papers) and Dialysis and Renal Disease Management (2 papers). Matt Devalaraja is often cited by papers focused on Erythropoietin and Anemia Treatment (2 papers), Iron Metabolism and Disorders (2 papers) and Dialysis and Renal Disease Management (2 papers). Matt Devalaraja collaborates with scholars based in United States, Italy and United Kingdom. Matt Devalaraja's co-authors include Larry Lo, Michael Davidson, Pablo E. Pérgola, Douglas Kling, Dominic S. Raj, G. Kees Hovingh, Paul M. Ridker, Florian M.M. Baeres, Peter Libby and Milana Ivkovic and has published in prestigious journals such as The Lancet, Journal of the American Society of Nephrology and Journal of Investigative Dermatology.

In The Last Decade

Matt Devalaraja

7 papers receiving 535 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

2021 433 citations Paul M. Ridker, Matt Devalaraja et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matt Devalaraja United States	6	196	133	130	127	122	8	541
Milana Ivkovic Denmark	3	176 0.9×	124 0.9×	125 1.0×	117 0.9×	112 0.9×	3	440
Abdalrahman Zarzour United States	9	167 0.9×	104 0.8×	75 0.6×	160 1.3×	65 0.5×	11	505
Hirotaka Kimura Japan	10	159 0.8×	145 1.1×	141 1.1×	171 1.3×	142 1.2×	19	558
Arne Yndestad Norway	13	221 1.1×	58 0.4×	166 1.3×	139 1.1×	88 0.7×	19	608
Maaike Heslinga Netherlands	8	159 0.8×	39 0.3×	70 0.5×	64 0.5×	49 0.4×	19	534
Cibo Huang China	15	162 0.8×	51 0.4×	42 0.3×	162 1.3×	74 0.6×	45	657
Е Н Александрова Russia	11	161 0.8×	45 0.3×	46 0.4×	90 0.7×	66 0.5×	210	610
S Yano Japan	10	156 0.8×	175 1.3×	92 0.7×	68 0.5×	54 0.4×	30	546
Yutaka Furumitsu Japan	11	130 0.7×	41 0.3×	98 0.8×	124 1.0×	47 0.4×	18	596
Sigrun Badrnya Austria	10	169 0.9×	93 0.7×	124 1.0×	196 1.5×	69 0.6×	16	593

Countries citing papers authored by Matt Devalaraja

Since Specialization

Citations

This map shows the geographic impact of Matt Devalaraja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Devalaraja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Devalaraja more than expected).

Fields of papers citing papers by Matt Devalaraja

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matt Devalaraja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Devalaraja. The network helps show where Matt Devalaraja may publish in the future.

Co-authorship network of co-authors of Matt Devalaraja

This figure shows the co-authorship network connecting the top 25 collaborators of Matt Devalaraja. A scholar is included among the top collaborators of Matt Devalaraja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matt Devalaraja. Matt Devalaraja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Palle, Sirish, et al.. (2023). GUT-BIOME MODULATION WITH HUMAN MILK OLIGOSACCHARIDE (HMO) BASED SYNBIOTIC FOR A COMPLETE AND DEEP REMISSION IN CROHN’S DISEASE: A CASE STUDY. Inflammatory Bowel Diseases. 29(Supplement_1). S78–S79. 2 indexed citations

2.

Barrows, Ian R., Matt Devalaraja, Rahul Kakkar, et al.. (2022). Race, Interleukin‐6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease. Journal of the American Heart Association. 11(18). e025627–e025627. 6 indexed citations

3.

Ridker, Paul M., Matt Devalaraja, Florian M.M. Baeres, et al.. (2021). IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial. The Lancet. 397(10289). 2060–2069. 433 indexed citations breakdown →

4.

Pérgola, Pablo E., Matt Devalaraja, Steven Fishbane, et al.. (2020). Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. Journal of the American Society of Nephrology. 32(1). 211–222. 54 indexed citations

5.

Nowak, Kristen L., Rahul Kakkar, Matt Devalaraja, et al.. (2020). A Phase 1 Randomized Dose-Escalation Study of a Human Monoclonal Antibody to IL-6 in CKD. Kidney360. 2(2). 224–235. 8 indexed citations

6.

Spoto, Belinda, Patrizia Pizzini, Claudia Torino, et al.. (2019). FP379ERYTHROFERRONE PREDICTS MORTALITY AND CARDIOVASCULAR EVENTS IN CKD AND IN HEMODIALYSIS PATIENTS: A TWO COHORTS STUDY. Nephrology Dialysis Transplantation. 34(Supplement_1).

7.

Kakkar, Rahul, Larry Lo, Matt Devalaraja, et al.. (2019). Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study. Journal of Clinical Medicine. 8(4). 523–523. 20 indexed citations

8.

Murray, Clare, Kim Ahrens, Matt Devalaraja, et al.. (2015). Use of a Canine Model of Atopic Dermatitis to Investigate the Efficacy of a CCR4 Antagonist in Allergen-Induced Skin Inflammation in a Randomized Study. Journal of Investigative Dermatology. 136(3). 665–671. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact